vaccines
-
December 14, 2020
U-M outlines approach for COVID-19 vaccinations on campus
U-M has begun receiving the COVID-19 vaccine and will start vaccinating its health care workers as the first step in a program to eventually distribute the vaccine throughout the university.
-
November 30, 2020
Older adults say they’ll get COVID-19 vaccine but want to wait
U-M’s National Poll on Healthy Aging showed that 58 percent of adults aged 50 to 80 — one of the highest-priority groups for vaccination — say they are somewhat or very likely to get vaccinated to prevent COVID-19.
-
November 23, 2020
Majority of Detroiters unlikely to get COVID-19 vaccine
Sixty-one percent of Detroiters say they are unlikely or very unlikely to get a government-approved COVID-19 vaccine when it becomes available, according to U-M’s Detroit Metro Area Communities Study.
-
October 20, 2020
Epidemiologist Arnold Monto to lead COVID-19 vaccine hearings
Arnold Monto, a leading epidemiologist at the School of Public Health, will serve as acting chair of the Vaccines and Related Biological Products Advisory Committee meeting.
-
September 8, 2020
Flu shot options available for campus employees
With building closures and social distancing, fewer campus flu shot clinics are available this year, but whether working on campus or remotely, U-M faculty and staff have several options to get a flu vaccination.
-
September 1, 2020
U-M to conduct clinical trial to test COVID-19 vaccine
Michigan Medicine is partnering with the pharmaceutical company AstraZeneca for a Phase III clinical trial to test a vaccine against COVID-19, looking at how well the investigational vaccine works and how safe it is.
-
August 13, 2020
Firms must share information for massive, rapid vaccine production
U-M law professor Nicholson Price says companies should share information about manufacturing now so that the pending massive scale-up production can be as smooth as possible.
-
January 8, 2020
Vaccines now covered in pharmacies and doctor’s offices
U-M benefit plans now cover approved vaccinations under employees’ pharmacy and medical plans. Approved vaccines require no co-pay. Coverage is a prevention benefit in all U-M plans.
-
March 27, 2017
U-M findings offer new ideas that could speed vaccines to market
Vaccine development is largely trial and error—which results in years of pricey development and just a 6 percent success rate—but a U-M researcher believes he’s found a way to potentially improve those numbers.
- « Previous
- 1
- …
- 3
- 4
- 5